Gonzalo Perez

Summary

Country: Colombia

Publications

  1. ncbi Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women
    Gonzalo Perez
    National Research Center, Group Saludcoop, Bogota, Colombia
    Int J Cancer 122:1311-8. 2008
  2. ncbi Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
    Nubia Munoz
    Division of Research and Public Health, National Institute of Cancer, Bogota, Colombia
    J Natl Cancer Inst 102:325-39. 2010

Detail Information

Publications2

  1. ncbi Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women
    Gonzalo Perez
    National Research Center, Group Saludcoop, Bogota, Colombia
    Int J Cancer 122:1311-8. 2008
    ..These data support vaccination of adolescents and young adults in the region, which is expected to greatly reduce the burden of cervical and genital cancers, precancers and genital warts...
  2. ncbi Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
    Nubia Munoz
    Division of Research and Public Health, National Institute of Cancer, Bogota, Colombia
    J Natl Cancer Inst 102:325-39. 2010
    ....